{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:20:57Z","timestamp":1792700457675,"version":"4.5.0"},"reference-count":46,"publisher":"American Society for Clinical Investigation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1172\/jci99081","type":"journal-article","created":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T18:00:45Z","timestamp":1531677645000},"page":"3558-3567","source":"Crossref","is-referenced-by-count":281,"title":["Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models"],"prefix":"10.1172","volume":"128","author":[{"given":"Alex","family":"McCampbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio S.","family":"Tomassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Setnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah L.","family":"Hoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Shabsovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Thankamony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit","family":"Cudkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Frank","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Kordasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Swayze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1996.tb00907.x"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8209258"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.09.020"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0596-43"},{"issue":"Pt 10","key":"B5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/120.10.1723","article-title":"Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia","volume":"120","author":"Andersen","year":"1997","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.8.1451"},{"issue":"Pt 8","key":"B7","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/brain\/awt097","article-title":"Is SOD1 loss of function involved in amyotrophic lateral sclerosis?","volume":"136","author":"Saccon","year":"2013","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25424"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70061-9"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.05.009"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2107-13.2013"},{"issue":"374","key":"B12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.04.042"},{"key":"B14","unstructured":"FDA approves first drug for spinal muscular atrophy. FDA. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm534611.htm. Published December 23, 2016. Updated March 28, 2018. Accessed June 1, 2018"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.4.nnr70007"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20708"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24237"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2011.01.045"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040998"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.04.032"},{"issue":"1","key":"B22","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3582-16.2017"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.593"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-313521"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80705"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5384.1851"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2660"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1688-8"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086137"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607496113"},{"key":"B32","unstructured":"FDA grants accelerated approval to first drug for Duchenne muscular dystrophy. FDA. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm521263.htm. Published September 19, 2016. Updated September 26, 2018. Accessed June 1, 2018"},{"issue":"208","key":"B33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318835110"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.04.006"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.211"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24618"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5053-11.2012"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606201104"},{"issue":"5","key":"B40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2010.06683.x","article-title":"Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS","volume":"113","author":"Gros-Louis","year":"2010","journal-title":"J Neurochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm1559"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3109\/17482968.2012.724074"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004960"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2017.02.001"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-767-5_20"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2037-14.2014"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/99081\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T03:53:27Z","timestamp":1720410807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/99081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,1]]},"published-print":{"date-parts":[[2018,8,1]]}},"alternative-id":["10.1172\/JCI99081"],"URL":"https:\/\/doi.org\/10.1172\/jci99081","relation":{},"ISSN":["0021-9738","1558-8238"],"issn-type":[{"value":"0021-9738","type":"print"},{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]}}}